Financhill
Sell
40

ABBV Quote, Financials, Valuation and Earnings

Last price:
$175.33
Seasonality move :
1.78%
Day range:
$170.66 - $176.80
52-week range:
$153.09 - $207.32
Dividend yield:
3.53%
P/E ratio:
60.97x
P/S ratio:
5.61x
P/B ratio:
51.44x
Volume:
17.5M
Avg. volume:
7.6M
1-year change:
15.75%
Market cap:
$310.3B
Revenue:
$54.3B
EPS (TTM):
$2.88
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $33.3B $45.8B $56.2B $58.1B $54.3B
Revenue Growth (YoY) 1.57% 37.69% 22.69% 3.3% -6.44%
 
Cost of Revenues $7.4B $15.4B $17.4B $17.4B $20.4B
Gross Profit $25.8B $30.4B $38.8B $40.6B $33.9B
Gross Profit Margin 77.64% 66.41% 68.96% 70% 62.42%
 
R&D Expenses $6.8B $7.8B $8B $7.2B $8.5B
Selling, General & Admin $6.9B $11.3B $12.3B $15.3B $12.9B
Other Inc / (Exp) -$3B -$5.7B -$2.6B -$2.6B -$4.8B
Operating Expenses $12.8B $19.1B $20.8B $22.5B $21.1B
Operating Income $13B $11.4B $17.9B $18.1B $12.8B
 
Net Interest Expenses $1.5B $2.3B $2.4B $2B $1.7B
EBT. Incl. Unusual Items $8.4B $3.4B $13B $13.5B $6.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $544M -$1.2B $1.4B $1.6B $1.4B
Net Income to Company $7.9B $4.6B $11.5B $11.8B $4.9B
 
Minority Interest in Earnings -- -$6M -$7M -$9M -$10M
Net Income to Common Excl Extra Items $7.9B $4.6B $11.5B $11.8B $4.9B
 
Basic EPS (Cont. Ops) $5.30 $2.73 $6.48 $6.65 $2.73
Diluted EPS (Cont. Ops) $5.28 $2.72 $6.45 $6.63 $2.72
Weighted Average Basic Share $1.5B $1.7B $1.8B $1.8B $1.8B
Weighted Average Diluted Share $1.5B $1.7B $1.8B $1.8B $1.8B
 
EBITDA $12.2B $12.3B $23.9B $24.2B $17.2B
EBIT $10.2B $5.9B $15.4B $15.7B $8.5B
 
Revenue (Reported) $33.3B $45.8B $56.2B $58.1B $54.3B
Operating Income (Reported) $13B $11.4B $17.9B $18.1B $12.8B
Operating Income (Adjusted) $10.2B $5.9B $15.4B $15.7B $8.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $12.9B $14.3B $14.8B $13.9B $14.5B
Revenue Growth (YoY) 52.16% 11.16% 3.28% -5.98% 3.83%
 
Cost of Revenues $5.1B $4.4B $5B $6.5B $4.2B
Gross Profit $7.9B $10B $9.8B $7.4B $10.2B
Gross Profit Margin 60.86% 69.39% 66.1% 53.44% 70.87%
 
R&D Expenses $1.8B $2.1B $1.7B $1.7B $2.1B
Selling, General & Admin $2.8B $3.1B $3.3B $3.4B $4.2B
Other Inc / (Exp) -$135M -$33M $294M $4M -$1.2B
Operating Expenses $4.6B $5.6B $5.2B $5.1B $6.3B
Operating Income $3.3B $4.3B $4.6B $2.3B $3.9B
 
Net Interest Expenses $620M $585M $497M $398M $591M
EBT. Incl. Unusual Items $2.5B $3.7B $4.4B $2B $2.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $187M $508M $448M $172M $520M
Net Income to Company $2.3B $3.2B $4B $1.8B $1.6B
 
Minority Interest in Earnings -$5M -$1M -$3M -$3M -$3M
Net Income to Common Excl Extra Items $2.3B $3.2B $3.9B $1.8B $1.6B
 
Basic EPS (Cont. Ops) $1.30 $1.78 $2.22 $1.00 $0.88
Diluted EPS (Cont. Ops) $1.29 $1.78 $2.21 $1.00 $0.88
Weighted Average Basic Share $1.8B $1.8B $1.8B $1.8B $1.8B
Weighted Average Diluted Share $1.8B $1.8B $1.8B $1.8B $1.8B
 
EBITDA $5.4B $6.4B $7.2B $4.7B $4.9B
EBIT $3.1B $4.3B $5B $2.5B $2.8B
 
Revenue (Reported) $12.9B $14.3B $14.8B $13.9B $14.5B
Operating Income (Reported) $3.3B $4.3B $4.6B $2.3B $3.9B
Operating Income (Adjusted) $3.1B $4.3B $5B $2.5B $2.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $40.7B $55.2B $57.8B $55.1B $55.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $12.7B $17.8B $17.6B $18.9B $18.2B
Gross Profit $27.9B $37.4B $40.3B $36.3B $37.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $7.2B $8B $7.4B $7.8B $8.7B
Selling, General & Admin $10B $12.3B $15.1B $13.1B $14.1B
Other Inc / (Exp) -$1.5B -$7B -$767M -$5.8B -$5.4B
Operating Expenses $16.4B $20.8B $22.6B $20.7B $22.8B
Operating Income $11.6B $16.6B $17.7B $15.6B $14.5B
 
Net Interest Expenses $2.1B $2.4B $2.1B $1.8B $1.9B
EBT. Incl. Unusual Items $8B $7.2B $14.8B $8B $7.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $594M -$331M $1.4B $1.5B $2.1B
Net Income to Company $7.4B $7.5B $13.4B $6.5B $5.1B
 
Minority Interest in Earnings -$4M -$8M -$11M -$7M -$11M
Net Income to Common Excl Extra Items $7.4B $7.5B $13.4B $6.5B $5.1B
 
Basic EPS (Cont. Ops) $4.75 $4.22 $7.55 $3.67 $2.89
Diluted EPS (Cont. Ops) $4.73 $4.20 $7.49 $3.65 $2.88
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $15.3B $18.3B $25.3B $19B $18.2B
EBIT $10.4B $9.7B $17B $10.2B $9.9B
 
Revenue (Reported) $40.7B $55.2B $57.8B $55.1B $55.5B
Operating Income (Reported) $11.6B $16.6B $17.7B $15.6B $14.5B
Operating Income (Adjusted) $10.4B $9.7B $17B $10.2B $9.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $31.9B $41.3B $42.9B $40B $41.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $10.7B $13.1B $13.2B $14.7B $12.5B
Gross Profit $21.2B $28.2B $29.7B $25.3B $28.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $5.6B $5.8B $5.2B $5.7B $6B
Selling, General & Admin $8.1B $9.1B $11.8B $9.7B $10.9B
Other Inc / (Exp) -$1B -$2.3B -$535M -$3.7B -$4.3B
Operating Expenses $13.6B $15.3B $17.1B $15.2B $16.9B
Operating Income $7.6B $12.9B $12.6B $10.1B $11.8B
 
Net Interest Expenses $1.7B $1.8B $1.6B $1.3B $1.6B
EBT. Incl. Unusual Items $4.9B $8.7B $10.5B $5B $6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $321M $1.2B $1.1B $989M $1.7B
Net Income to Company $4.6B $7.5B $9.4B $4B $4.3B
 
Minority Interest in Earnings -$4M -$6M -$10M -$8M -$9M
Net Income to Common Excl Extra Items $4.6B $7.5B $9.4B $4B $4.3B
 
Basic EPS (Cont. Ops) $2.86 $4.20 $5.26 $2.27 $2.42
Diluted EPS (Cont. Ops) $2.85 $4.19 $5.23 $2.27 $2.42
Weighted Average Basic Share $4.9B $5.3B $5.3B $5.3B $5.3B
Weighted Average Diluted Share $4.9B $5.3B $5.3B $5.3B $5.3B
 
EBITDA $11.1B $17.1B $18.5B $13.3B $14.4B
EBIT $6.7B $10.6B $12.2B $6.7B $8.1B
 
Revenue (Reported) $31.9B $41.3B $42.9B $40B $41.2B
Operating Income (Reported) $7.6B $12.9B $12.6B $10.1B $11.8B
Operating Income (Adjusted) $6.7B $10.6B $12.2B $6.7B $8.1B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $39.9B $8.4B $9.7B $9.2B $12.8B
Short Term Investments -- $30M $84M $28M $2M
Accounts Receivable, Net $5.4B $8.8B $10B $11.3B $11.2B
Inventory $1.8B $3.3B $3.1B $3.6B $4.1B
Prepaid Expenses $2.4B $3.6B -- -- --
Other Current Assets -- -- $5B $4.4B $4.9B
Total Current Assets $49.5B $24.2B $27.9B $28.5B $33B
 
Property Plant And Equipment $3B $5.2B $5.1B $4.9B $5B
Long-Term Investments $93M $293M $277M $241M $304M
Goodwill $15.6B $33.1B $32.4B $32.2B $32.3B
Other Intangibles $18.6B $82.9B $76B $67.4B $55.6B
Other Long-Term Assets $2.3B $4.9B $4.9B $5.6B $8.5B
Total Assets $89.1B $150.6B $146.5B $138.8B $134.7B
 
Accounts Payable $1.5B $2.3B $2.9B $2.9B $3.7B
Accrued Expenses $8.6B $15.5B $17.3B $19.8B $24.2B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $15.6B $28.7B $35.2B $29.5B $37.8B
 
Long-Term Debt $63B $77.6B $64.2B $59.1B $52.2B
Capital Leases -- -- -- -- --
Total Liabilities $97.3B $137.5B $131.1B $121.5B $124.3B
 
Common Stock $18M $18M $18M $18M $18M
Other Common Equity Adj -- -- -$2.9B -$2.2B -$2.3B
Common Equity -$8.2B $13.1B $15.4B $17.3B $10.4B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- $21M $28M $33M $37M
Total Equity -$8.2B $13.1B $15.4B $17.3B $10.4B
 
Total Liabilities and Equity $89.1B $150.6B $146.5B $138.8B $134.7B
Cash and Short Terms $39.9B $8.5B $9.8B $9.2B $12.8B
Total Debt $66.7B $86.1B $76.7B $63.3B $59.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $7.9B $12.2B $11.8B $13.3B $7.3B
Short Term Investments $60M $67M $47M $3M $28M
Accounts Receivable, Net $8.4B $9.3B $10.7B $11.4B $11.5B
Inventory $3.5B $3.1B $3.2B $4B $4.5B
Prepaid Expenses $3.2B $4.3B $4.6B -- --
Other Current Assets -- -- -- $4.5B $4.6B
Total Current Assets $23B $29B $30.4B $33.2B $27.8B
 
Property Plant And Equipment $5B $5.1B $4.9B $4.9B $5.1B
Long-Term Investments $246M $272M $235M $275M $267M
Goodwill $42.8B $32.3B $31.7B $32.1B $35.3B
Other Intangibles $74.6B $77.5B $68.7B $58.6B $66.6B
Other Long-Term Assets $3.9B $4.7B $5.4B $7.1B $8.3B
Total Assets $149.6B $148.9B $141.3B $136.2B $143.4B
 
Accounts Payable -- -- -- -- --
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $24.2B $28.5B $32.7B $34.8B $43.1B
 
Long-Term Debt $82.3B $74B $60.4B $55.6B $58.5B
Capital Leases -- -- -- -- --
Total Liabilities $134.3B $135.3B $125.3B $124.1B $137.4B
 
Common Stock $18M $18M $18M $18M $18M
Other Common Equity Adj -- -- -- -$2.4B -$2.3B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $19M $27M $33M $35M $39M
Total Equity $15.3B $13.6B $16B $12.1B $6.1B
 
Total Liabilities and Equity $149.6B $148.9B $141.3B $136.2B $143.4B
Cash and Short Terms $8B $12.2B $11.9B $13.3B $7.3B
Total Debt $87.1B $80.7B $69.6B $60.7B $71.1B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $7.9B $4.6B $11.5B $11.8B $4.9B
Depreciation & Amoritzation $2B $6.5B $8.5B $8.5B $8.7B
Stock-Based Compensation $430M $753M $692M $671M $747M
Change in Accounts Receivable -$74M -$929M -$1.3B -$1.5B $66M
Change in Inventories -$231M -$40M -$142M -$686M -$417M
Cash From Operations $13.3B $17.6B $22.8B $24.9B $22.8B
 
Capital Expenditures $552M $798M $787M $695M $777M
Cash Acquisitions -$1.1B -$39.6B -$1.9B -$794M -$1.2B
Cash From Investing $596M -$37.6B -$2.3B -$623M -$2B
 
Dividends Paid (Ex Special Dividend) -$6.4B -$7.7B -$9.3B -$10B -$10.5B
Special Dividend Paid
Long-Term Debt Issued $31.5B $3B $1B $2B --
Long-Term Debt Repaid -$5.2B -$5.7B -$9.4B -$14.4B -$4.1B
Repurchase of Common Stock -$629M -$978M -$934M -$1.5B -$2B
Other Financing Activities -$552M -$333M -$674M -$1.1B -$742M
Cash From Financing $18.7B -$11.5B -$19B -$24.8B -$17.2B
 
Beginning Cash (CF) $7.3B $39.9B $8.4B $9.7B $9.2B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $32.6B -$31.5B $1.4B -$483M $3.6B
Ending Cash (CF) $39.9B $8.4B $9.7B $9.2B $12.8B
 
Levered Free Cash Flow $12.8B $16.8B $22B $24.2B $22.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $2.3B $3.2B $4B $1.8B $1.6B
Depreciation & Amoritzation $2.3B $2.1B $2.2B $2.2B $2.1B
Stock-Based Compensation $162M $135M $126M $130M $181M
Change in Accounts Receivable -$31M $590M $357M $2M $344M
Change in Inventories $111M $219M -$17M -$55M -$64M
Cash From Operations $5.8B $7.9B $7.6B $7.6B $5.4B
 
Capital Expenditures $217M $217M $177M $219M $249M
Cash Acquisitions -$880M -$492M -$100M -$157M -$8.5B
Cash From Investing -$1.1B -$615M $1.3B -$369M -$8.3B
 
Dividends Paid (Ex Special Dividend) -$2.1B -$2.3B -$2.5B -$2.6B -$2.8B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $1B -- -- --
Long-Term Debt Repaid -$651M -$2.2B -$2.7B -$2M -$403M
Repurchase of Common Stock -$20M -$6M -$4M -$4M -$17M
Other Financing Activities -$75M -$146M -$320M -$64M $32M
Cash From Financing -$2.8B -$3.6B -$5.5B -$2.7B -$3.1B
 
Beginning Cash (CF) $6B $8.5B $8.5B $8.8B $13.1B
Foreign Exchange Rate Adjustment $6M -$41M -$59M -$16M $8M
Additions / Reductions $1.9B $3.7B $3.4B $4.5B -$5.9B
Ending Cash (CF) $7.9B $12.2B $11.8B $13.3B $7.3B
 
Levered Free Cash Flow $5.6B $7.7B $7.4B $7.4B $5.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $7.4B $7.5B $13.4B $6.5B $5.1B
Depreciation & Amoritzation $4.9B $8.6B $8.3B $8.8B $8.4B
Stock-Based Compensation $696M $699M $668M $754M $872M
Change in Accounts Receivable -$441M -$927M -$1.8B -$689M $159M
Change in Inventories -$23M $123M -$628M -$683M -$95M
Cash From Operations $16B $22.6B $22.6B $25.5B $16.5B
 
Capital Expenditures $682M $879M $669M $785M $888M
Cash Acquisitions -$39.9B -$1.2B -$1.6B -$970M -$19.3B
Cash From Investing -$37.5B -$1.8B -$1.3B -$1.7B -$19.7B
 
Dividends Paid (Ex Special Dividend) -$7.2B -$9B -$9.9B -$10.4B -$10.9B
Special Dividend Paid
Long-Term Debt Issued -- $1B $2B -- $20B
Long-Term Debt Repaid -- -$6.9B -$11.3B -$9.2B -$10.7B
Repurchase of Common Stock -$684M -$1.1B -$1.6B -$2B -$1.4B
Other Financing Activities -$424M -$587M -$992M -$1B -$100M
Cash From Financing $18.8B -$16.4B -$21.5B -$22.4B -$2.8B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$2.7B $4.3B -$237M $1.5B -$6B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $15.3B $21.7B $21.9B $24.7B $15.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $4.6B $7.5B $9.4B $4B $4.3B
Depreciation & Amoritzation $4.4B $6.5B $6.3B $6.6B $6.3B
Stock-Based Compensation $617M $563M $539M $622M $747M
Change in Accounts Receivable -$574M -$572M -$1B -$273M -$180M
Change in Inventories -$193M -$30M -$516M -$513M -$191M
Cash From Operations $12.7B $17.7B $17.5B $18.1B $11.8B
 
Capital Expenditures $519M $600M $482M $572M $683M
Cash Acquisitions -$39.2B -$837M -$494M -$670M -$18.7B
Cash From Investing -$36.9B -$1.2B -$175M -$1.2B -$18.9B
 
Dividends Paid (Ex Special Dividend) -$5.6B -$6.9B -$7.5B -$7.9B -$8.3B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $3B $1B $2B -- $20B
Long-Term Debt Repaid -$4.4B -$5.7B -$7.6B -$2.4B -$8.9B
Repurchase of Common Stock -$682M -$803M -$1.5B -$2B -$1.4B
Other Financing Activities -$204M -$458M -$776M -$685M -$43M
Cash From Financing -$7.8B -$12.7B -$15.2B -$12.8B $1.7B
 
Beginning Cash (CF) $87.1B $26.8B $24.4B $24.7B $44B
Foreign Exchange Rate Adjustment -$32M -$69M -$85M -$18M -$19M
Additions / Reductions -$32B $3.8B $2.2B $4.1B -$5.5B
Ending Cash (CF) $55B $30.5B $26.5B $28.8B $38.5B
 
Levered Free Cash Flow $12.2B $17.1B $17B $17.5B $11.1B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is down 0.51% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.38% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.32% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock